Reviewed by the PeptideMind Team · Updated August 5, 2026
Survodutide Peptide Dosage Guide, Benefits & Side Effects
Survodutide (BI 456906) dosing guide: schedule, titration & side effects for the GLP-1/GCGR dual agonist that cut body weight up to 16.6% in Phase 3 trials.
As seen on
Survodutide Dosage Schedule
A gradual step up to the full maintenance dose over several months, giving your body time to adjust while curbing appetite and ramping up calorie burn. Also being studied for its benefit in MASH, a liver condition.
Survodutide Standard Weight-Loss Titration
16 weeks with the dose increasing over time, focused on weight management.
1 days per week
Taken Monday in the morning.
1.2–4.8 mg
Starts at 1.2 mg and increases to 4.8 mg over 4 phases as your body adjusts. Injected just under the skin in the abdomen or thigh.
Survodutide is an experimental weekly injection being studied for weight loss. It works by curbing appetite and boosting the number of calories your body burns, and early studies show it also helps with a liver condition called MASH.
What is Survodutide?
Survodutide is a lab-made, injectable peptide that acts on two different hormone pathways at once to reduce appetite, slow digestion, and increase how many calories your body burns. It's being developed by a major pharmaceutical company and tested in late-stage trials for obesity, type 2 diabetes, fatty liver disease, and heart health outcomes.
Weight
sur
Metabolic
Our top-rated vendor
Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing, no paid placements, no affiliate influence. We update this list as new data comes in.
Based on current scores, this vendor ranks highest across those criteria.
What Does Survodutide Do?
It activates two separate hormone receptors at once: one slows digestion and curbs appetite, while the other tells the liver to break down fat and raises the number of calories the body burns. Combining both effects tends to produce more weight loss than targeting just one of these pathways alone.
Two receptors at once
Activates two separate hormone receptors simultaneously.
Curbs appetite
One slows digestion and curbs appetite.
Burns fat
The other tells the liver to break down fat and raises calorie burn.
Survodutide Targeted areas
Frequently Asked Questions About Survodutide
Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.
Survodutide Reconstitution Guide
Survodutide is supplied as a freeze-dried powder that must be mixed into a injectable solution before use. Available in 5mg, 10mg, 20mg sizes.
5 mg lyophilized vial
Survodutide is supplied as a freeze-dried powder that must be mixed into a injectable solution before use. Available in 5mg, 10mg, 20mg sizes.
2 mL bacteriostatic water
Adding 2 mL of bac water to a 5 mg vial gives a workable concentration for syringe dosing. More water makes microdosing easier; less concentrates each draw.
Storage after mixing
Freeze the dry powder for up to three years, or refrigerate it for up to two. Once mixed with bacteriostatic water, refrigerate and use within about a month — don't shake it, and keep it away from light. After reconstitution, keep the vial refrigerated and use within 30 days.
Reconstitution steps
Remove caps & sanitize stoppers
Attach needle to syringe
Draw 2 mL bacteriostatic water
Insert needle into Survodutide vial
Release water gently down the side
Swirl to dissolve — don't shake
Check for full dissolution
Refrigerate Survodutide — good for 30 days
Chemical Makeup
16
Amino Acids
Survodutide
Ala
APosition 1
Met
MPosition 2
Ile
IPosition 3
Asn
NPosition 4
Pyl
OPosition 5
Ala
APosition 6
Cys
CPosition 7
Ile
IPosition 8
Asp
DPosition 9
Pro
PPosition 10
Glu
EPosition 11
Pro
PPosition 12
Thr
TPosition 13
Ile
IPosition 14
Asp
DPosition 15
Glu
EPosition 16
What Are the Benefits of Survodutide?
What research says it may help with, and how it works in the body.
weight loss
After 16 weeks, it outperformed semaglutide for weight loss, producing an 8.7% reduction in body weight compared to 5.3%.
It works in two ways at once: reducing how much food energy you take in and increasing how much energy your body burns.
At the 4.8mg dose, people lost an average of 14.9% of their body weight after 46 weeks, and 55% of them lost 15% or more.
metabolic
63-67% of people reduced their liver fat by 30% or more.
At the highest doses, it lowered long-term blood sugar levels (HbA1c) by up to 1.6%.
At the 4.8mg dose, 62% of people saw their fatty liver disease (MASH) improve without their liver scarring getting any worse.
What Are the Side Effects of Survodutide?
Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.
Who Should Avoid It
Not recommended in pregnancy or breastfeeding
Use contraception during treatment
Stop Right Away If You Notice
Severe persistent nausea/vomiting preventing oral intake
Signs of pancreatitis (severe abdominal pain radiating to back)
Allergic reactions (rash, itching, difficulty breathing)
Severe hypoglycemia with insulin/sulfonylureas
Gallbladder symptoms (right upper quadrant pain)
Significant tachycardia or arrhythmias
Milder Signs to Watch For
Is Survodutide FDA approved?
Survodutide is not an FDA-approved drug. It is intended for research purposes only and is not approved for human consumption, diagnostic, or therapeutic use.
Research Use Only
Survodutide has not been evaluated by the FDA for safety or efficacy in humans.
No Clinical Oversight
Not manufactured under FDA-regulated quality or clinical standards.
Unregulated Sourcing
Purity, dosing, and sourcing are not verified through FDA testing or oversight.
Survodutide Cycle Length: How Long Should It Last?
This breaks down how long a typical Survodutide cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.
That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.
- Week 1-4
- Possible nausea, reduced appetite (most common during escalation)
- Week 4-8
- Initial weight loss begins; improved satiety between meals
- Week 8-16
- Progressive weight loss; potential energy level improvements
- Week 16-24
- Approaching steady-state; more consistent effects
- Week 0-0
- Sustained weight loss; average 15-19% by week 46
Survodutide Research References
It is a phase 3 compound
Survodutide
Survodutide is a phase 3 compound
293 participants with biopsy-confirmed MASH; 48 weeks. MASH improvement: 62% (4.8mg) vs 14% placebo; 63-67% achieved ≥30% liver fat reduction.
2024
Head-to-head vs semaglutide 1.0mg; 16 weeks. Survodutide -8.7% weight loss vs semaglutide -5.3%; HbA1c reduction up to -1.6%.
2023
387 participants; BMI ≥27 kg/m²; 46 weeks. 14.9% mean weight loss at 4.8mg; 83% achieved ≥5%, 69% achieved ≥10%, 55% achieved ≥15%.
2024